Taking stock of the drug industry, from the lab to the medicine chestJuly 25, 2023Check out STAT+Sponsored By By Ed SilvermanPharmalot Columnist, Senior Writer Jon Cherry/Getty Images STAT+ | South Africa faces court hearing over opaque Covid-19 vaccine contracts A hearing began in a South Africa court on Tuesday to determine whether the government overpaid for Covid-19 vaccines. By Ed Silverman STAT+ | Drug from Stoke shows lower activity against childhood epilepsy, prompting search for better dose The company is still seeking an effective dose for an experimental drug to treat a severe form of childhood epilepsy. By Adam Feuerstein STAT+ | As Alzheimer's drugs hit the market, the race for early detection blood tests heats up The increasing use of biomarkers in diagnostic tests is prompting neurologists to redefine Alzheimer's by biology rather than symptoms. By Brittany Trang Steven Senn/AP STAT+ | Biogen says it will cut costs by $700 million, slash 1,000 jobs The company also released second quarter sales and earnings that handily topped the forecasts of Wall Street analysts. By Matthew Herper and Damian Garde STAT+ | Truvian presents data for its desktop blood-testing device in a field still in Theranos's shadow The results support Truvian's vision of decentralized clinical testing, but resurface questions about an approach associated with Theranos. By Jonathan Wosen More around STATCheck out more exclusive coverage with a STAT+ subscriptionRead premium in-depth biotech, pharma, policy, and life science coverage and analysis with all of our STAT+ articles.Enjoying Pharmalot? Tell us about your experienceContinue reading the latest health & science news with the STAT appDownload on the App Store or get it on Google Play STAT, 1 Exchange Place, Boston, MA©2023, All Rights Reserved.I no longer wish to receive STAT emailsUpdate Newsletter Preferences • Contact Us • Advertise with Us • View in Browser
No comments